Neuronal expression of myeloperoxidase is increased in Alzheimer's disease
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Myeloperoxidase, a heme protein expressed by professional phagocytic cells, generates an array of oxidants which are proposed to contribute to tissue damage during inflammation. We now report that enzymatically active myeloperoxidase and its characteristic amino acid oxidation products are present in human brain. Further, expression of myeloperoxidase is increased in brain tissue showing Alzheimer's neuropathology. Consistent with expression in phagocytic cells, myeloperoxidase immunoreactivity was present in some activated microglia in Alzheimer brains. However, the majority of immunoreactive material in brain localized with amyloid plaques and, surprisingly, neurons including granule and pyramidal neurons of the hippocampus. Confirming neuronal localization of the enzyme, several neuronal cell lines as well as primary neuronal cultures expressed myeloperoxidase protein. Myeloperoxidase mRNA was also detected in neuronal cell lines. These results reveal the unexpected presence of myeloperoxidase in neurons. The increase in neuronal myeloperoxidase expression we observed in Alzheimer disease brains raises the possibility that the enzyme contributes to the oxidative stress implicated in the pathogenesis of the neurodegenerative disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · cited 2×
“Oxidative damage occurs early in the neurodegenerative process (Nunomura et al. 2001) and co-localization of oxidative stress markers with both neurofibrillary tangles (Good et al.”
BackgroundFormation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
Eiserich, J. P., Hristova, M., Cross, C. E., Jones, A. D., Freeman, B. A., Halliwell, B., & van der Vliet, A. (1998) · Nature · doi:10.1038/34923 · Cited by 1,496
McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
The metallobiology of Alzheimer's disease
Bush, A. I. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00067-5 · Cited by 1,315
Daugherty, A., Dunn, J. L., Rateri, D. L., & Heinecke, J. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117342 · Cited by 1,269 · cited 7×
“Myeloperoxidase expression has previously only been described in neutrophils (Nauseef 1988), monocytes (Nauseef 1988), and certain populations of tissue macrophages (Daugherty et al. 1994; Nagra et al. 1997; Sugiyama et al. 2001).”
BackgroundMethodInfluentialSelf-citationWidespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Boehning, D., & Snyder, S. H. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131047 · Cited by 1,225
Risk of Alzheimer's disease and duration of NSAID use
Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. (1997) · Neurology · doi:10.1212/wnl.48.3.626 · Cited by 1,132 · cited 1×
“…that AD is a chronic inflammatory process (Beal 1994; Yankner 1996; Markesbery 1997) and epidemiological studies suggest that antiinflammatory drugs retard the rate of deterioration of patients suffering from AD (Breitner et al. 1992; McGeer et al. 1996; Stewart et al. 1997; Zandi et al. 2002).”
BackgroundEvidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037 · cited 6×
“Several markers of oxidative stress are increased in brain tissue from Alzheimer’s patients, including advanced glycation end products (AGEs; Vitek et al. 1994; Yan et al. 1994), o,o¢-dityrosine (Hensley et al. 1998), lipid oxidation products (Sayre et al. 1997; Pratico et al. 1998), protein carbonyls (Smith et al. 19…”
BackgroundInfluentialSayre, L. M., Zelasko, D. A., Harris, P. L. R., Perry, G., Salomon, R. G., & Smith, M. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052092.x · Cited by 1,007
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
Yankner, B. A. (1996) · Neuron · doi:10.1016/s0896-6273(00)80115-4 · Cited by 955
Studies on the chlorinating activity of myeloperoxidase.
Harrison, J. E., & Schultz, J. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33749-3 · Cited by 928
Hazen, S. L., & Heinecke, J. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119379 · Cited by 842
Self-citationAdvanced glycation end products contribute to amyloidosis in Alzheimer disease
Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., & Cerami, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4766 · Cited by 806 · cited 9×
“Several markers of oxidative stress are increased in brain tissue from Alzheimer’s patients, including advanced glycation end products (AGEs; Vitek et al. 1994; Yan et al. 1994), o,o¢-dityrosine (Hensley et al. 1998), lipid oxidation products (Sayre et al. 1997; Pratico et al. 1998), protein carbonyls (Smith et al. 19…”
BackgroundInfluentialAdvanced Maillard reaction end products are associated with Alzheimer disease pathology.
Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stern, D., Sayre, L. M., Monnier, V. M., & Perry, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5710 · Cited by 714
Sugiyama, S., Okada, Y., Sukhova, G. K., Virmani, R., Heinecke, J. W., & Libby, P. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64036-9 · Cited by 699
Self-citationThe neutrophil: Function and clinical disorders
Clark, R. A., & Klebanoff, S. J. (1978) · Cited by 669
Evidence of neuronal oxidative damage in Alzheimer's disease.
Good, P. F., Werner, P., Hsu, A., Olanow, C. W., & Perl, D. P. (1996) · Europe PMC (PubMed Central) · Cited by 663
The neutrophil: Function and clinical disorders
Sbarra, A. J. (1979) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(79)90450-x · Cited by 624
Breitner, J. C. S., Gau, B. A., Welsh, K. A., Plassman, B. L., McDonald, W. M., Helms, M. J., & Anthony, J. C. (1994) · Neurology · doi:10.1212/wnl.44.2.227 · Cited by 568
Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.
Yan, S. D., Chen, X., Schmidt, A. M., Brett, J., Godman, G., Zou, Y. S., Scott, C. W., Caputo, C., Frappier, T., & Smith, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7787 · Cited by 565
Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau.
Greenberg, S. G., Davies, P., Schein, J. D., & Binder, L. I. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48531-6 · Cited by 543
Hensley, K., Maidt, M. L., Yu, Z., Sang, H., Markesbery, W. R., & Floyd, R. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08126.1998 · Cited by 507
Increased Nuclear DNA Oxidation in the Brain in Alzheimer's Disease
Gabbita, S. P., Lovell, M. A., & Markesbery, W. R. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052034.x · Cited by 478
Mitochondria, free radicals, and neurodegeneration
Beal, M. F. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80100-0 · Cited by 424
Increased F 2 ‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo
Pratico, D., Lee, V. M.-Y., Trojanowski, J. Q., Rokach, J., & Fitzgerald, G. A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1777 · Cited by 405 · cited 5×
“1997), lipid oxidation products (Sayre et al. 1997; Pratico et al. 1998), and oxidized DNA (Mecocci et al.”
BackgroundInfluentialAnderson, M. M., Hazen, S. L., Hsu, F. F., & Heinecke, J. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119176 · Cited by 389
Self-citationLeeuwenburgh, C., Rasmussen, J. E., Hsu, F. F., Mueller, D. M., Pennathur, S., & Heinecke, J. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3520 · Cited by 361
Self-citationTyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins.
Heinecke, J. W., Li, W., Francis, G. A., & Goldstein, J. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116531 · Cited by 354
Self-citationAnderson, M. M., Requena, J. R., Crowley, J. R., Thorpe, S. R., & Heinecke, J. W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3042 · Cited by 349
Self-citationSavenkova, M. L., Mueller, D. M., & Heinecke, J. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32005-7 · Cited by 335
Self-citationSchweers, O., Mandelkow, E. M., Biernat, J., & Mandelkow, E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8463 · Cited by 334
Myeloperoxidase Polymorphism Is Associated with Gender Specific Risk for Alzheimer's Disease
Reynolds, W. F., Rhees, J., Maciejewski, D., Paladino, T., Sieburg, H., Maki, R. A., & Masliah, E. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6977 · Cited by 322
Reduced incidence of AD with NSAID but not H2receptor antagonists: The Cache County Study
Zandi, P. P., Anthony, J. C., Hayden, K. M., Mehta, K., Mayer, L., & Breitner, J. C. S. (2002) · Neurology · doi:10.1212/wnl.59.6.880 · Cited by 316
Perry, G., Nunomura, A., Hirai, K., Zhu, X., Prez, M., Avila, J., Castellani, R. J., Atwood, C. S., Aliev, G., Sayre, L. M., et al. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01113-9 · Cited by 297
Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis
Nagra, R. M., Becher, B., Tourtellotte, W. W., Antel, J. P., Gold, D., Paladino, T., Smith, R. A., Nelson, J. R., & Reynolds, W. F. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00089-1 · Cited by 283
Gaut, J. P., Yeh, G. C., Tran, H. D., Byun, J., Henderson, J. P., Richter, G. M., Brennan, M.-L., Lusis, A. J., Belaaouaj, A., Hotchkiss, R. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211190298 · Cited by 262
Self-citation[53] Assays for the chlorination activity of myeloperoxidase
Kettle, A. J., & Winterbourn, C. C. (1994) · Methods in Enzymology · doi:10.1016/s0076-6879(94)33056-5 · Cited by 261
Inflammation, Atherosclerosis, and Ischemic Events — Exploring the Hidden Side of the Moon
Maseri, A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361409 · Cited by 228
Leukocytic Oxygen Activation and Microbicidal Oxidative Toxin
Hurst, J. K., & Barrette, W. C. (1989) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238909082555 · Cited by 228
Formation of o-tyrosine and dityrosine in proteins during radiolytic and metal-catalyzed oxidation
Huggins, T. G., Wells-Knecht, M. C., Detorie, N. A., Baynes, J. W., & Thorpe, S. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31395-4 · Cited by 223
Smith, M. A., Sayre, L. M., Anderson, V. E., Harris, P. L. R., Beal, M. F., Kowall, N., & Perry, G. (1998) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549804600605 · Cited by 222
Hou, L., Kang, I., Marchant, R. E., & Zagorski, M. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200338200 · Cited by 218
Fraser, P. E., Nguyen, J. T., Chin, D. T., & Kirschner, D. A. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08470.x · Cited by 212
McLellan, M. E., Kajdasz, S. T., Hyman, B. T., & Bacskai, B. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02212.2003 · Cited by 174
Self-citationWong, A., Lüth, H.-J., Deuther-Conrad, W., Dukic-Stefanovic, S., Gasic-Milenkovic, J., Arendt, T., & Münch, G. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02872-4 · Cited by 160
Heinecke, J. W. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90061-6 · Cited by 149
Self-citationOxidative Regulation of Fatty Acid-Induced Tau Polymerization
Gamblin, T. C., King, M. E., Kuret, J., Berry, R. W., & Binder, L. I. (2000) · Biochemistry · doi:10.1021/bi001876l · Cited by 149
Henderson, J. P., Byun, J., Takeshita, J., & Heinecke, J. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303928200 · Cited by 141
Self-citationHyman, B. T., Tanzi, R. E., Marzloff, K., Barbour, R., & Schenk, D. (1992) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199201000-00009 · Cited by 135
Self-citationOxidation of Methionine 35 Attenuates Formation of Amyloid β-Peptide 1–40 Oligomers
Palmblad, M., Westlind-Danielsson, A., & Bergquist, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112218200 · Cited by 132
Byun, J., Henderson, J. P., Mueller, D. M., & Heinecke, J. W. (1999) · Biochemistry · doi:10.1021/bi9822980 · Cited by 105
Self-citationNauseef, W. M. (1988) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30634-8 · Cited by 103
STELMASZYŃSKA, T., & ZGLICZYNSKI, J. M. (1978) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1978.tb12748.x · Cited by 92
MPO and APOEε4 polymorphisms interact to increase risk for AD in Finnish males
Reynolds, W. F., Hiltunen, M., Pirskanen, M., Mannermaa, A., Helisalmi, S., Lehtovirta, M., Alafuzoff, I., & Soininen, A. H. (2000) · Neurology · doi:10.1212/wnl.55.9.1284 · Cited by 90
Rakita, R. M., Michel, B. R., & Rosen, H. (1990) · Biochemistry · doi:10.1021/bi00456a033 · Cited by 86
Association between Alzheimer's Disease and a Functional Polymorphism in the Myeloperoxidase Gene
Crawford, F., Freeman, M. J., Schinka, J. A., Morris, M. D., Abdullah, L. I., Richards, D., Sevush, S., Duara, R., & MULLAN, M. J. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7560 · Cited by 58
Jolivalt, C. G., Leininger‐Muller, B., Drożdż, R., Naskalski, J. W., & Siest, G. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12661-6 · Cited by 52
Experimental developments in movement disorders: update on proposed free radical mechanisms
Przedborski, S., & Jackson-Lewis, V. R. (1998) · Current Opinion in Neurology · doi:10.1097/00019052-199808000-00009 · Cited by 49
Yan, L., Lodge, J. K., Traber, M. G., Matsugo, S., & Packer, L. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37223-0 · Cited by 44
Taylor, K. L., Pohl, J., & Kinkade, J. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74037-x · Cited by 41
Energy, oxidative damage, and Alzheimer's disease: Clues to the underlying puzzle
Beal, M. F. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90198-8 · Cited by 40
Cited by
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Myeloperoxidase: friend and foe
Klebanoff, S. J. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1204697 · Cited by 2,282
“MPO has also been detected in increased amounts in certain Alzheimer brain neurons [489].”
BackgroundMaes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Chlorinative stress: An under appreciated mediator of neurodegeneration?
Yap, Y. W., Whiteman, M., & Cheung, N. S. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.06.013 · Cited by 570
Hopperton, K. E., Mohammad, D., Trépanier, M. O., Giuliano, V, & Bazinet, R. P. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.246 · Cited by 622
Metadata
- Authors
- Green, P. S., Mendez, A. J., Jacob, J. S., Crowley, J. R., Growdon, W., Hyman, B. T., & Heinecke, J. W.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2004-07-02
- Volume
- 90
- Issue
- 3
- Pages
- 724-733
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2035299293
- Cited by
- 331
- References
- 66
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.